February 1, 2007 - Issue 215 |
||
Back | ||
Think Piece What about the Bio-Weapons Labs? By Sherwood Ross |
||
Printer Friendly Plain Text Format
|
||
According to the non-profit Sunshine Project of Austin, Texas, some
113 university, government, hospital and corporate laboratories engaged
in research tied to germ warfare, have refused to disclose their operations
to the public as required by law, a nonprofit watchdog agency says. Despite
this, the National Institutes of Health (NIH), in From Under A Problem of Secrecy Edward Hammond of the Sunshine Project
explains that he had found grave safety problems as the government-funded
labs engage in so-called “dual-use research,” where researchers learn
how to use pathogens for either offensive or defensive purposes. Francis
Boyle, an international legal expert at the On November 7th, 2006, “Honoring these requests is not only mandatory under the NIH Guidelines that you are charged with enforcing [but] transparency is also a moral duty of institutions that conduct research, such as rDNA and select agent work that could endanger the public,” Hammond wrote. He added, “Failing prompt compliance by these institutions we note that your office must do its duty under NIH Guidelines and terminate funding.” More War Profiteering Since 9/11, big name pharmaceutical houses, military laboratories,
and State and private universities across As reported by the Washington
Post on Christmas 2006, the Battelle National Biodefense
Institute of Columbus, “Some of the research falls within a legal gray zone, skirting the edges of an international treaty outlawing the production of even small amounts of biological weapons. The administration dismisses these concerns, insisting that the work ... is purely defensive. The Bush administration has rejected calls for oversight by independent observers outside the [Homeland Security] department’s network of government scientists and contractors,” the Post added. Milton Leitenberg, a weapons expert at the Hammond believes there are about 400 bio-weapons agents labs across the U.S., some of which encounter unexpected difficulty complying with federal law. David Perlin, president of the Public Health Research Institute (PHRI) of Newark, N.J., told Sunshine that the FBI requested PHRI to enter into an agreement with the Bureau “not to publicly disclose which specific pathogens and/or strains are stored at our facility.” Those who dismiss NIH’s laxity about enforcing its regulations only
need recall the anthrax attacks on Congress and the media in October
2001. The deadly strain released back then most probably came
from the Lack of transparencey is cause for concern if only because of the
history of CIA and Pentagon experiments in germ warfare that used Americans
as guinea pigs. In Between 1949 and 1969, the Army tested the spread of dangerous chemical
and bacterial organisms over 239 Jackie Cabasso, executive director of Western States Legal Foundation,
Oakland, California, warned, “[In 2001], the U.S. single-handedly blew
apart an international system for inspections of these kinds of [biological]
laboratories, a system that would have made great strides toward ensuring
that biodefense labs aren’t abused for offensive purposes. Having
thumbed our nose at the world, the According to Boyle, President Bush “sabotaged the Inspection Protocol
for the BWC” as it was on the verge of conclusion and success and the In 2003, the New York Times quoted
Elisa Harris, former arms control official under President Clinton,
who discussed the wisdom of the government’s plan for a mobile germ
trainer. Harris said that the Bush administration plan would
raise concerns among other governments in part because the List of the Culprits Among pharmaceutical houses in non-compliance with NIH requirements are Abbott Laboratories of Abbott Park and Worchester, Agencourt Bioscience Corp.; Antibody Science, Inc.; BASF Plant Science, Bristol-Myers Squibb and its Pharmaceutical Research Institute of Connecticut; Centocor, Inc.; Chiron; Discovery Genomics Inc.; DuPont Central Research and Development; Embrex, Inc.; Genentech, Inc., Genzyme Corp. of Cambridge and Framingham, Mass.; GlaxoSmithKline, Merck & Co., Inc. and its Rahway, N.J., research site; Integral Molecular; Introgen Therapeutics; L2 Diagnostics LLC; Merck & Co. Inc., West Point; Merck Research Laboratories, Rahway, N.J.; Meridian Bioscience Inc.; Monsanto Co. Mystic, Conn., research; New Link Genetics; NovaFlora, Inc.; NovoBiotic Pharmaceuticals; OSI Pharmaceuticals; Pfizer Inc., and Pfizer Pharmaceuticals of St. Louis, Roche Bioscience, Schering-Plough Research Institute; SelectX Pharmaceuticals; Serono Research Institution; Third Wave Technologies; and Vaxin, Inc. Federal entities involved include the Center for Disease Control, the Walter Reed Army Medical Center, VA hospitals in Stratton, Va.; the Jerry Pettis Memorial Hospital and the VA Pittsburgh Healthcare System, the Idaho National Laboratory, Lawrence Livermore National Laboratory, the Oak Ridge National Laboratory, Plum Island Animal Disease Center of the U.S. Department of Homeland Security, the U.S. Department of Agriculture, and Walter Reed Army Institute of Research and Navy Medical Research Center. Other fund recipients include, AERAS Global TB Vaccine Foundation, CBR Institute for Biomedical Research, Inc.; Children’s Hospital Oakland Research Institute, Children’s National Medical Center, Cincinnati Children’s Hospital Medical Center, Columbus Children’s Research Institute, Hadassah Medical Organization, Lovelace Respiratory Research Institute, Memorial Sloan-Kettering Cancer Center, Mystic Aquarium & Institute for Exploration, and Scripps Clinic. Among universities in non-compliance: Alabama A&M, Albany Medical College, Ball State, Brigham Young, Bucknell, Central Michigan, Drexel College of Medicine, Hackensack University Medical Center, Hunter College, Indiana State University, Purdue University, Loma Linda, Missouri State, New York Medical College, and Queens College of City University of New York, Rider (Delaware), Rockefeller University, Rosalind Franklin University of Medicine and Science, South Dakota State University, St. John’s University, State University of New York at Binghamton, Brockport, and Buffalo; Towson, Robert Wood Johnson Medical School (UMDNJ), and University Medical Center of Southern Nevada, and universities of Arizona, California at San Francisco, Maryland, Massachusetts, Miami, Fla.; Mississippi; Puerto Rico, Rhode Island, Southern Mississippi, Texas at Arlington and San Antonio, Tulsa, Utah State, Wake Forest, Washington University in St. Louis, Western Kentucky and Wilkes (Pennsylvania). Sherwood Ross is an American reporter who has worked for major American newspapers and magazines as well as international wire services. To comment on this article or arrange for speaking engagements: [email protected]. His blog is The Smirking Chimp. |
||
Back | ||